[REGN] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
08-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -55.32%
YoY- -31.45%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 2,422,900 2,169,500 1,927,800 1,582,447 1,226,827 1,098,077 802,329 20.20%
PBT 1,224,600 889,800 676,200 554,767 341,527 227,289 221,287 32.96%
Tax 75,400 97,800 -144,200 381,248 88,412 72,295 111,111 -6.25%
NP 1,149,200 792,000 820,400 173,519 253,115 154,994 110,176 47.76%
Tax Rate -6.16% -10.99% 21.33% -68.72% -25.89% -31.81% -50.21% -
Total Cost 1,273,700 1,377,500 1,107,400 1,408,928 973,712 943,083 692,153 10.68%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 47.43 36.51 42.56 10.97 20.63 14.12 13.73 22.92%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 10.90 7.25 7.58 1.62 2.41 1.49 0.89 51.76%
EPS Diluted 10.24 6.93 7.15 1.49 2.19 1.34 0.79 53.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.